SBRA (Sabra Healthcare REIT, Inc.) Stock Analysis - SEC Filings

Sabra Healthcare REIT, Inc. (SBRA) is a publicly traded Real Estate sector company. As of May 21, 2026, SBRA trades at $21.02 with a market cap of $5.28B and a P/E ratio of 33.39. SBRA moved +0.19% today. Year to date, SBRA is +10.38%; over the trailing twelve months it is +16.55%. Its 52-week range spans $15.60 to $21.28. Analyst consensus is buy with an average price target of $22.33. Rallies surfaces SBRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find SBRA SEC filings?

Rallies organizes SBRA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

SBRA Key Metrics

Key financial metrics for SBRA
MetricValue
Price$21.02
Market Cap$5.28B
P/E Ratio33.39
EPS$0.63
Dividend Yield0.30%
52-Week High$21.28
52-Week Low$15.60
Volume0
Avg Volume0
Revenue (TTM)$812.84M
Net Income$156.02M
Gross Margin0.00%

Latest SBRA News

Recent SBRA Insider Trades

  • FLORES JESSICA sold 15.23K (~$302.49K) on Mar 25, 2026.

SBRA Analyst Consensus

7 analysts cover SBRA: 0 strong buy, 2 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $22.33.

Common questions about SBRA

Where can I find SBRA SEC filings?
Rallies organizes SBRA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show SBRA 10-K and 10-Q filings?
Rallies organizes SBRA SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is SBRA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SBRA. It does not provide personalized investment advice.
SBRA

SBRA